List Name |
Annotation |
Enrichment |
p-value |
neurogenesis |
AmiGO Browser |
3.37 |
5.39e-03 |
neurite development |
AmiGO Browser |
4.51 |
5.44e-03 |
neuron development |
AmiGO Browser |
3.75 |
0.01 |
generation of neurons |
AmiGO Browser |
3.19 |
0.01 |
actin polymerization and/or depolymerization |
AmiGO Browser |
6.13 |
0.01 |
axonogenesis |
AmiGO Browser |
4.35 |
0.01 |
post-Golgi vesicle-mediated transport |
AmiGO Browser |
10.37 |
0.02 |
neuron morphogenesis during differentiation |
AmiGO Browser |
4.15 |
0.02 |
neurite morphogenesis |
AmiGO Browser |
4.15 |
0.02 |
cell part morphogenesis |
AmiGO Browser |
3.42 |
0.02 |
cell projection morphogenesis |
AmiGO Browser |
3.42 |
0.02 |
cell projection organization and biogenesis |
AmiGO Browser |
3.42 |
0.02 |
barbed-end actin filament capping |
AmiGO Browser |
9.63 |
0.02 |
actin filament capping |
AmiGO Browser |
9.63 |
0.02 |
negative regulation of actin filament depolymerization |
AmiGO Browser |
9.41 |
0.02 |
peptide transport |
AmiGO Browser |
9.41 |
0.02 |
actin filament depolymerization |
AmiGO Browser |
8.99 |
0.02 |
regulation of actin filament depolymerization |
AmiGO Browser |
8.99 |
0.02 |
cellular morphogenesis during differentiation |
AmiGO Browser |
3.78 |
0.02 |
neuron differentiation |
AmiGO Browser |
3.02 |
0.03 |
membrane fusion |
AmiGO Browser |
7.78 |
0.03 |
drug transport |
AmiGO Browser |
33.71 |
0.03 |
establishment of organelle localization |
AmiGO Browser |
7.36 |
0.03 |
phosphatidylinositol metabolic process |
AmiGO Browser |
28.90 |
0.03 |
antigen processing and presentation of endogenous peptide antigen via MHC class I |
AmiGO Browser |
25.28 |
0.04 |
antigen processing and presentation of endogenous peptide antigen |
AmiGO Browser |
25.28 |
0.04 |
organelle localization |
AmiGO Browser |
6.42 |
0.04 |
regulation of actin polymerization and/or depolymerization |
AmiGO Browser |
6.13 |
0.04 |
neuron migration |
AmiGO Browser |
5.95 |
0.04 |
negative regulation of cell growth |
AmiGO Browser |
5.95 |
0.04 |
negative regulation of cell size |
AmiGO Browser |
5.95 |
0.04 |
antigen processing and presentation of endogenous antigen |
AmiGO Browser |
20.23 |
0.05 |
protein depolymerization |
AmiGO Browser |
5.62 |
0.05 |
cell morphogenesis |
AmiGO Browser |
2.12 |
0.05 |
cellular structure morphogenesis |
AmiGO Browser |
2.12 |
0.05 |
regulation of actin filament length |
AmiGO Browser |
5.54 |
0.05 |
regulation of cell size |
AmiGO Browser |
2.87 |
0.05 |
regulation of progression through S phase |
AmiGO Browser |
18.39 |
0.05 |
lymph node development |
AmiGO Browser |
18.39 |
0.05 |
regulation of S phase of mitotic cell cycle |
AmiGO Browser |
18.39 |
0.05 |
oligopeptide transport |
AmiGO Browser |
18.39 |
0.05 |
negative regulation of cell organization and biogenesis |
AmiGO Browser |
5.25 |
0.06 |
Golgi to endosome transport |
AmiGO Browser |
16.86 |
0.06 |
thermoregulation |
AmiGO Browser |
16.86 |
0.06 |
protein stabilization |
AmiGO Browser |
15.56 |
0.06 |
Golgi vesicle transport |
AmiGO Browser |
3.32 |
0.06 |
anatomical structure morphogenesis |
AmiGO Browser |
1.66 |
0.06 |
negative regulation of growth |
AmiGO Browser |
4.87 |
0.06 |
keratinization |
AmiGO Browser |
13.48 |
0.07 |
blastocyst development |
AmiGO Browser |
13.48 |
0.07 |
Golgi organization and biogenesis |
AmiGO Browser |
13.48 |
0.07 |
L-amino acid transport |
AmiGO Browser |
12.64 |
0.08 |
ER-associated protein catabolic process |
AmiGO Browser |
12.64 |
0.08 |
misfolded or incompletely synthesized protein catabolic process |
AmiGO Browser |
12.64 |
0.08 |
nervous system development |
AmiGO Browser |
1.74 |
0.08 |
positive regulation of axonogenesis |
AmiGO Browser |
11.90 |
0.08 |
patterning of blood vessels |
AmiGO Browser |
11.24 |
0.09 |
mammary gland development |
AmiGO Browser |
11.24 |
0.09 |
S phase of mitotic cell cycle |
AmiGO Browser |
11.24 |
0.09 |
negative regulation of progression through mitotic cell cycle |
AmiGO Browser |
11.24 |
0.09 |
endothelial cell differentiation |
AmiGO Browser |
11.24 |
0.09 |
S phase |
AmiGO Browser |
11.24 |
0.09 |
induction of apoptosis via death domain receptors |
AmiGO Browser |
11.24 |
0.09 |
actin filament-based process |
AmiGO Browser |
2.39 |
0.09 |
heme biosynthetic process |
AmiGO Browser |
10.65 |
0.09 |
positive regulation of neurogenesis |
AmiGO Browser |
10.65 |
0.09 |
negative regulation of apoptosis |
AmiGO Browser |
2.35 |
0.09 |
negative regulation of programmed cell death |
AmiGO Browser |
2.33 |
0.10 |
tetrapyrrole biosynthetic process |
AmiGO Browser |
9.63 |
0.10 |
porphyrin biosynthetic process |
AmiGO Browser |
9.63 |
0.10 |
axon cargo transport |
AmiGO Browser |
9.63 |
0.10 |
insulin secretion |
AmiGO Browser |
9.63 |
0.10 |
vesicle targeting |
AmiGO Browser |
9.63 |
0.10 |
peptide cross-linking |
AmiGO Browser |
9.63 |
0.10 |
regulation of protein stability |
AmiGO Browser |
9.63 |
0.10 |
retrograde vesicle-mediated transport, Golgi to ER |
AmiGO Browser |
9.19 |
0.10 |